Navigation Links
Despite Recessionary Pressures, Patient and Surgeon Demand Will Drive the Joint Arthroplasty and Fixation Bone Cement Market by 7% Annually Through 2013
Date:10/6/2009

WALTHAM, Mass., Oct. 6 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, patients and surgeons are driving demand for elective orthopedic procedures. Recessionary pressures slowed growth in joint arthroplasty procedures between 2008 and 2009; however, novel technology, such as hip resurfacing and joint revision implants, is enabling a wider range of patients to be treated in the US, Europe, and Japan, while the burgeoning middle classes in Brazil, China, and India are opting for elective joint replacement procedures and driving global growth by 7% annually through 2013.

MRG's Global Markets for Bone Cement and Accessories 2009 report finds that as device benefits emerge, their adoption will increase in all countries under study. The resulting procedure volume growth will propel sales of bone cement, cement mixing/delivery systems, and cement spacer molds. The prefabricated cement spacer mold segment will outperform the overall market, with 10% annual growth fueled by the release of positive clinical data for this relatively new technology.

In the US and Europe, a two-stage revision procedure has become the standard of care for treating infected hip and knee arthroplasties. Silicone-based cement spacer molds allow the surgeon to create an antibiotic cement implant in the shape of a prosthetic hip or knee implant. This antibiotic-loaded implant preserves normal leg length, allows for early patient mobilization, and quickly delivers the antibiotics locally to the periprosthetic space, to prevent further infection.

"Although cement spacer molds are gaining surgeon acceptance, the relatively high device price can be prohibitive, particularly in facilities with restricted budgets and in countries where patients pay for the vast majority of medical expenses out-of-pocket," says Melissa Hussey, Analyst at MRG. "As of 2009, China and India had not approved the use of cement spacer molds, and their adoption has been limited in Brazil due to the additional cost they add to the procedure. Globally, however, the market for cement spacer molds will grow considerably over the next five years."

MRG's new report, Global Markets for Bone Cement and Accessories 2009 provides important insight into surgical trends that will fuel device use and market growth through 2013. Additionally, the report provides full breakdowns of cemented hip, knee, and small-joint replacement procedures by type and unit sales for bone cement, cement mixing and delivery systems, and cement spacer molds by subtype, including five-year forecasts, up-to-date country-level market shares, and in-depth qualitative insights.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com

SOURCE Millennium Research Group


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
2. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
3. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
4. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
5. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
6. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
7. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
8. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
9. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
10. Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
11. Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):